首页> 美国卫生研究院文献>other >Twenty year Risk of Prostate Cancer Death by Midlife Prostate specific Antigen and a Panel of Four Kallikrein Markers in a Large Population based Cohort of Healthy Men

【2h】

Twenty year Risk of Prostate Cancer Death by Midlife Prostate specific Antigen and a Panel of Four Kallikrein Markers in a Large Population based Cohort of Healthy Men

机译：在中年人的健康人群中中年前列腺特异性抗原和一组激肽释放酶标记物导致的前列腺癌死亡的二十年风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundProstate-specific antigen (PSA) screening reduces prostate cancer deaths but leads to harm from overdiagnosis and overtreatment.

机译：背景前列腺特异性抗原（PSA）筛查可减少前列腺癌的死亡，但会因过度诊断和过度治疗而造成伤害。

著录项

期刊名称 other
作者
Daniel D. Sjoberg; Andrew J. Vickers; Melissa Assel; Anders Dahlin; Bing Ying Poon; David Ulmert; Hans Gösta Lilja;
展开▼
作者单位

展开▼
年(卷),期 -1(73),6
年度 -1
页码 941–948
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
Prostate-specific antigen Kallikrein Screening;

机译：前列腺特异性抗原;激肽释放酶;筛选;

相似文献

外文文献
中文文献
专利

1. Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men [J] . Sjoberg Daniel D., Vickers Andrew J., Assel Melissa, European urology . 2018,第6期

机译：中期前列腺特异性抗原和四个Kallikrein标志物中的2年前列腺癌死亡风险和四个Kallikrein标志物中的大量基于人口的健康男性
2. Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study [J] . Stattin Par, Vickers Andrew J., Sjoberg Daniel D., European urology . 2015,第2期

机译：使用前列腺特异抗原和一组激肽释放酶标记物提高筛查致死性前列腺癌的特异性：巢式病例对照研究
3. Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2015,第2期

机译：回复：使用前列腺特异性抗原和一组激肽释放酶标记物提高筛查致死性前列腺癌的特异性：一项嵌套的病例对照研究社论评论
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Prostate Specific Antigen Dynamics and Prostate Cancer Risk: A Population-Based Study [D] . Hird, Amanda Elizabeth. 2021

机译：前列腺特异性抗原动力学和前列腺癌风险：基于人群的研究
6. A panel of kallikrein marker predicts prostate cancer in a large population-based cohort followed for 15 years without screening [O] . Andrew Vickers, Amit Gupta, Caroline J. Savage, -1

机译：Kallikrein标记的一组在没有筛选的情况下预测大型人口的队列中的前列腺癌
7. Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men [O] . Daniel D. Sjoberg, Andrew J. Vickers, Melissa Assel, 2018

机译：中期前列腺特异性抗原和四个Kallikrein标记的2年前列腺癌死亡风险在一个大于基于人口的健康男性的群体

Twenty year Risk of Prostate Cancer Death by Midlife Prostate specific Antigen and a Panel of Four Kallikrein Markers in a Large Population based Cohort of Healthy Men

摘要

著录项

相似文献

相关主题

期刊订阅